AssetMark’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$156K Buy
7,162
+1,149
+19% +$33.5K ﹤0.01% 1530
2026
Q2
$218K Buy
6,013
+2,090
+53% +$71.4K ﹤0.01% 1416
2026
Q1
$130K Buy
3,923
+335
+9% +$14.2K ﹤0.01% 1458
2025
Q4
$166K Sell
3,588
-963
-21% -$40.3K ﹤0.01% 1345
2025
Q3
$159K Buy
4,551
+352
+8% +$12.2K ﹤0.01% 1321
2025
Q2
$124K Sell
4,199
-310
-7% -$8.84K ﹤0.01% 1322
2025
Q1
$135K Sell
4,509
-180
-4% -$5.5K ﹤0.01% 1222
2024
Q4
$134K Sell
4,689
-202
-4% -$6.68K ﹤0.01% 1189
2024
Q3
$189K Sell
4,891
-524
-10% -$18.7K ﹤0.01% 1025
2024
Q2
$174K Buy
5,415
+514
+10% +$17.8K ﹤0.01% 1024
2024
Q1
$190K Sell
4,901
-544
-10% -$19K ﹤0.01% 950
2023
Q4
$168K Buy
5,445
+1,108
+26% +$27.8K ﹤0.01% 951
2023
Q3
$96.9K Buy
4,337
+281
+7% +$6.41K ﹤0.01% 993
2023
Q2
$87.2K Buy
4,056
+1,231
+44% +$27.9K ﹤0.01% 976
2023
Q1
$67.8K Buy
2,825
+885
+46% +$23.5K ﹤0.01% 967
2022
Q4
$45K Buy
1,940
+264
+16% +$5.32K ﹤0.01% 1067
2022
Q3
$27K Buy
1,676
+575
+52% +$10.1K ﹤0.01% 1074
2022
Q2
$20K Buy
1,101
+646
+142% +$10.9K ﹤0.01% 1114
2022
Q1
$9K Buy
+455
New +$8.6K ﹤0.01% 1201

Other funds holding COLL

AssetMark's COLL Position: Q3 2026 in Review

AssetMark increased its Collegium Pharmaceutical (COLL) stake by 19% in Q3 2026, buying an estimated $33.5K and bringing the position to 7,162 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

AssetMark first reported a position in COLL in Q1 2022 and has held it in 19 quarters since. The position peaked at $218K in Q2 2026. 189 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • AssetMark held 7,162 shares of Collegium Pharmaceutical worth $156K as of Q3 2026.
  • AssetMark bought 1,149 Collegium Pharmaceutical shares in Q3 2026, an estimated $33.5K.
  • Collegium Pharmaceutical made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1530 holding.
  • AssetMark first reported a position in Collegium Pharmaceutical in Q1 2022 and has held it in 19 quarters since.
  • AssetMark's Collegium Pharmaceutical position peaked at $218K in Q2 2026.
  • 189 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.